Anavex Life Sciences Corp (AVXL)

[TempePhil]

HCWainwright important points:

**Regarding possible Rett revenue, the following is a near quote from Dr.Missling, not exactly word for word, but very close:

Rett Syndrome and FTD and FragileX are not to be neglected. You can make a quick back of envelope calculation about how much revenue could be because rare diseases allow for higher prices.

(My comment-The company has been existing totally on share dilution for many years. This may change with rare disease approvals.)

**Rett Avatar TLD this year.

**Excellence patients increased from 84 to 96 patients, as regulatory agency requested additional age group grouping.
(My comment-Confirmation the company is actively discussing Excellence with regulatory. I don't like it when the goal posts are moved.)

**Alz on autopilot to conclude next year.